Skip to main content
Erschienen in: Tumor Biology 1/2015

01.01.2015 | Research Article

The expression profiles of microRNAs in Kaposi’s sarcoma

verfasst von: Xiu-Juan Wu, Xiong-Ming Pu, Zong-Feng Zhao, Ya-Nan Zhao, Xiao-Jing Kang, Wei-Dong Wu, Yun-Min Zou, Cao-Ying Wu, Yuan-Yuan Qu, De-Zhi Zhang, Yan-Yan Feng, Jian-Yong Liu

Erschienen in: Tumor Biology | Ausgabe 1/2015

Einloggen, um Zugang zu erhalten

Abstract

Kaposi’s sarcoma (KS) is a multicentric angioproliferative tumor of mesenchymal origin. The molecular and biologic aspects of KS are not fully understood. MicroRNAs are non-protein-coding small RNAs in the size range 19–25 nucleotides (nt) that play important roles in biological processes, including cellular differentiation, proliferation, and death. We performed a miRNA microarray analysis by detecting six paired KS and matched adjacent healthy tissues using the 7th generation of miRCURYTM LNA Array (v.18.0) (Exiqon) containing 3100 capture probes. We selected 10 significant differentially expressed miRNAs, which were confirmed by quantitative real-time reverse transcription polymerase chain reaction (qRT-PCR) in 18 paired KS and matched adjacent healthy tissue specimens. We also investigated the associations between clinical features and miRNA expression. Among the 3100 human miRNA probes in the microarrays, we identified 170 differentially expressed miRNAs (69 upregulated and 101 downregulated miRNAs) in KS versus adjacent healthy tissues. Among the most significantly upregulated miRNAs were miR-126-3p, miR-199a-3p, miR-16-5p, and the 13 KSHV-related miRNAs. The most significantly downregulated miRNAs included miR-125b-1-3p and miR-1183. Eight upregulated miRNAs, miR-181b-5p, miR-199a-3p, miR-15a-5p, miR-126-3p, miR-1297, kshv-miR-k12-12-3p, kshv-miR-k12-1-5p, and miR-16-5p, and two downregulated miRNAs, miR-125b-1-3p and miR-1183, were confirmed by qRT-PCR in 18 paired KS samples. The qRT-PCR results for 10 miRNAs were consistent with our microarray results. The miR-125b-1-3p and miR-16-5p had statistically significant associations with HHV-8 and HIV infections in KS. The results of miRNA profiling showed that KS appears to have unique expression patterns when compared with paired adjacent healthy tissues, suggesting that deregulation of miRNAs plays an important role in the progression of KS. These differentially expressed miRNAs may provide novel diagnostic and prognostic tools.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
2.
Zurück zum Zitat Engels BM, Hutvagner G. Principles and effects of microRNA-mediated post-transcriptional gene regulation. Oncogene. 2006;25(46):6163–9.CrossRefPubMed Engels BM, Hutvagner G. Principles and effects of microRNA-mediated post-transcriptional gene regulation. Oncogene. 2006;25(46):6163–9.CrossRefPubMed
4.
Zurück zum Zitat Farh KK-H, Grimson A, Jan C, Lewis BP, Johnston WK, Lim LP, et al. The widespread impact of mammalian microRNAs on mRNA repression and evolution. Science. 2005;310(5755):1817–21.CrossRefPubMed Farh KK-H, Grimson A, Jan C, Lewis BP, Johnston WK, Lim LP, et al. The widespread impact of mammalian microRNAs on mRNA repression and evolution. Science. 2005;310(5755):1817–21.CrossRefPubMed
5.
Zurück zum Zitat Houbaviy HB, Murray MF, Sharp PA. Embryonic stem cell-specific microRNAs. Dev Cell. 2003;5(2):351–8.CrossRefPubMed Houbaviy HB, Murray MF, Sharp PA. Embryonic stem cell-specific microRNAs. Dev Cell. 2003;5(2):351–8.CrossRefPubMed
6.
Zurück zum Zitat Reinhart BJ, Slack FJ, Basson M, Pasquinelli AE, Bettinger JC, Rougvie AE, et al. The 21-nucleotide let-7 RNA regulates developmental timing in Caenorhabditis elegans. Nature. 2000;403(6772):901–6.CrossRefPubMed Reinhart BJ, Slack FJ, Basson M, Pasquinelli AE, Bettinger JC, Rougvie AE, et al. The 21-nucleotide let-7 RNA regulates developmental timing in Caenorhabditis elegans. Nature. 2000;403(6772):901–6.CrossRefPubMed
7.
Zurück zum Zitat Stefani G, Slack FJ. Small non-coding RNAs in animal development. Nat Rev Mol Cell Biol. 2008;9(3):219–30.CrossRefPubMed Stefani G, Slack FJ. Small non-coding RNAs in animal development. Nat Rev Mol Cell Biol. 2008;9(3):219–30.CrossRefPubMed
8.
Zurück zum Zitat Hengge UR, Ruzicka T, Tyring SK, Stuschke M, Roggendorf M, Schwartz RA, et al. Update on kaposi’s sarcoma and other hhv8 associated diseases. Part 1: epidemiology, environmental predispositions, clinical manifestations, and therapy. Lancet Infect Dis. 2002;2(5):281–92.CrossRefPubMed Hengge UR, Ruzicka T, Tyring SK, Stuschke M, Roggendorf M, Schwartz RA, et al. Update on kaposi’s sarcoma and other hhv8 associated diseases. Part 1: epidemiology, environmental predispositions, clinical manifestations, and therapy. Lancet Infect Dis. 2002;2(5):281–92.CrossRefPubMed
9.
Zurück zum Zitat Wang HW, Trotter MW, Lagos D, Bourboulia D, Henderson S, Makinen T, et al. Kaposi sarcoma herpesvirus-induced cellular reprogramming contributes to the lymphatic endothelial gene expression in Kaposi sarcoma. Nat Genet. 2004;36(7):687–93.CrossRefPubMed Wang HW, Trotter MW, Lagos D, Bourboulia D, Henderson S, Makinen T, et al. Kaposi sarcoma herpesvirus-induced cellular reprogramming contributes to the lymphatic endothelial gene expression in Kaposi sarcoma. Nat Genet. 2004;36(7):687–93.CrossRefPubMed
10.
Zurück zum Zitat Kaposi M. Idiopathic multiple pigmented sarcoma of the skin. Arch Dermatol Syphilol. 1872;4(6):265–73.CrossRef Kaposi M. Idiopathic multiple pigmented sarcoma of the skin. Arch Dermatol Syphilol. 1872;4(6):265–73.CrossRef
11.
Zurück zum Zitat Kaloterakis A, Papasteriades C, Filiotou A, Economidou J, Hadjiyannis S, Stratigos J. Hla in familial and nonfamilial mediterranean Kaposi’s sarcoma in Greece. Tissue Antigens. 1995;45(2):117–9.CrossRefPubMed Kaloterakis A, Papasteriades C, Filiotou A, Economidou J, Hadjiyannis S, Stratigos J. Hla in familial and nonfamilial mediterranean Kaposi’s sarcoma in Greece. Tissue Antigens. 1995;45(2):117–9.CrossRefPubMed
12.
Zurück zum Zitat Dilnur P, Katano H, Wang ZH, Osakabe Y, Kudo M, Sata T, et al. Classic type of Kaposi’s sarcoma and human herpesvirus 8 infection in Xinjiang, China. Pathol Int. 2001;51(11):845–52.CrossRefPubMed Dilnur P, Katano H, Wang ZH, Osakabe Y, Kudo M, Sata T, et al. Classic type of Kaposi’s sarcoma and human herpesvirus 8 infection in Xinjiang, China. Pathol Int. 2001;51(11):845–52.CrossRefPubMed
13.
Zurück zum Zitat Pu X-M, Wu W-D, Ju H-E. The detection of hhv-8 in the serum of Kaposi’s sarcoma before and after the therapy with interferon. J Clin Dermatol. 2004;33(2):87–8. Pu X-M, Wu W-D, Ju H-E. The detection of hhv-8 in the serum of Kaposi’s sarcoma before and after the therapy with interferon. J Clin Dermatol. 2004;33(2):87–8.
14.
Zurück zum Zitat He F, Wang X, He B, Feng Z, Lu X, Zhang Y, et al. Human herpesvirus 8: serovprevalence and correlates in tumor patients from Xinjiang, China. J Med Virol. 2007;79(2):161–6.CrossRefPubMed He F, Wang X, He B, Feng Z, Lu X, Zhang Y, et al. Human herpesvirus 8: serovprevalence and correlates in tumor patients from Xinjiang, China. J Med Virol. 2007;79(2):161–6.CrossRefPubMed
15.
Zurück zum Zitat Wang X, He B, Zhang Z, Liu T, Wang H, Li X, et al. Human herpesvirus-8 in northwestern China: epidemiology and characterization among blood donors. Virol J. 2010;7(1):1–7.CrossRef Wang X, He B, Zhang Z, Liu T, Wang H, Li X, et al. Human herpesvirus-8 in northwestern China: epidemiology and characterization among blood donors. Virol J. 2010;7(1):1–7.CrossRef
16.
Zurück zum Zitat Wu XJ, Pu XM, Kang XJ, Halifu Y, An CX, Zhang DZ, Yakeya B, Mijit J. One hundred and five kaposi sarcoma patients: A clinical study in xinjiang, northwest of china. J Eur Acad Dermatol Venereol. 2014. Wu XJ, Pu XM, Kang XJ, Halifu Y, An CX, Zhang DZ, Yakeya B, Mijit J. One hundred and five kaposi sarcoma patients: A clinical study in xinjiang, northwest of china. J Eur Acad Dermatol Venereol. 2014.
17.
Zurück zum Zitat Chang Y, Cesarman E, Pessin MS, Lee F, Culpepper J, Knowles DM, et al. Identification of herpesvirus-like DNA sequences in aids-associated Kaposi’s sarcoma. Science. 1994;266(5192):1865–9.CrossRefPubMed Chang Y, Cesarman E, Pessin MS, Lee F, Culpepper J, Knowles DM, et al. Identification of herpesvirus-like DNA sequences in aids-associated Kaposi’s sarcoma. Science. 1994;266(5192):1865–9.CrossRefPubMed
19.
Zurück zum Zitat Gu H, Li H, Zhang L, Luan H, Huang T, Wang L, et al. Diagnostic role of microRNA expression profile in the serum of pregnant women with fetuses with neural tube defects. J Neurochem. 2012;122(3):641–9.CrossRefPubMed Gu H, Li H, Zhang L, Luan H, Huang T, Wang L, et al. Diagnostic role of microRNA expression profile in the serum of pregnant women with fetuses with neural tube defects. J Neurochem. 2012;122(3):641–9.CrossRefPubMed
20.
Zurück zum Zitat Schmittgen TD, Livak KJ. Analyzing real-time PCR data by the comparative ct method. Nat Protoc. 2008;3(6):1101–8.CrossRefPubMed Schmittgen TD, Livak KJ. Analyzing real-time PCR data by the comparative ct method. Nat Protoc. 2008;3(6):1101–8.CrossRefPubMed
21.
Zurück zum Zitat Jackson RJ, Standart N. How do microRNAs regulate gene expression? Sci Signal. 2007;2007(367):re1. Jackson RJ, Standart N. How do microRNAs regulate gene expression? Sci Signal. 2007;2007(367):re1.
22.
Zurück zum Zitat Zhang B, Pan X, Cobb GP, Anderson TA. MicroRNAs as oncogenes and tumor suppressors. Dev Biol. 2007;302(1):1–12.CrossRefPubMed Zhang B, Pan X, Cobb GP, Anderson TA. MicroRNAs as oncogenes and tumor suppressors. Dev Biol. 2007;302(1):1–12.CrossRefPubMed
23.
Zurück zum Zitat Landgraf P, Rusu M, Sheridan R, Sewer A, Iovino N, Aravin A, et al. A mammalian microRNA expression atlas based on small RNA library sequencing. Cell. 2007;129(7):1401–14.CrossRefPubMedPubMedCentral Landgraf P, Rusu M, Sheridan R, Sewer A, Iovino N, Aravin A, et al. A mammalian microRNA expression atlas based on small RNA library sequencing. Cell. 2007;129(7):1401–14.CrossRefPubMedPubMedCentral
24.
Zurück zum Zitat Ene AMC, Borze I, Guled M, Costache M, Leen G, Sajin M, et al. MicroRNA expression profiles in Kaposi’s sarcoma. Pathol Oncol Res. 2014;20(1):153–9.CrossRef Ene AMC, Borze I, Guled M, Costache M, Leen G, Sajin M, et al. MicroRNA expression profiles in Kaposi’s sarcoma. Pathol Oncol Res. 2014;20(1):153–9.CrossRef
25.
Zurück zum Zitat O’Hara AJ, Wang L, Dezube BJ, Harrington WJ, Damania B, Dittmer DP. Tumor suppressor microRNAs are underrepresented in primary effusion lymphoma and Kaposi sarcoma. Blood. 2009;113(23):5938–41.CrossRefPubMedPubMedCentral O’Hara AJ, Wang L, Dezube BJ, Harrington WJ, Damania B, Dittmer DP. Tumor suppressor microRNAs are underrepresented in primary effusion lymphoma and Kaposi sarcoma. Blood. 2009;113(23):5938–41.CrossRefPubMedPubMedCentral
26.
Zurück zum Zitat Chen L, Yang Q, Kong WQ, Liu T, Liu M, Li X, et al. MicroRNA-181b targets camp responsive element binding protein 1 in gastric adenocarcinomas. IUBMB Life. 2012;64(7):628–35.CrossRefPubMed Chen L, Yang Q, Kong WQ, Liu T, Liu M, Li X, et al. MicroRNA-181b targets camp responsive element binding protein 1 in gastric adenocarcinomas. IUBMB Life. 2012;64(7):628–35.CrossRefPubMed
27.
Zurück zum Zitat Nurul S, Yoke-Kqueen C, Sabariah AR, Shiran MS, Singh A, Learn-Han L. Differential microRNA expression and identification of putative miRNA targets and pathways in head and neck cancers. Int J Mol Med. 2011;28(3):327–36. Nurul S, Yoke-Kqueen C, Sabariah AR, Shiran MS, Singh A, Learn-Han L. Differential microRNA expression and identification of putative miRNA targets and pathways in head and neck cancers. Int J Mol Med. 2011;28(3):327–36.
28.
Zurück zum Zitat Ratert N, Meyer H-A, Jung M, Mollenkopf H-J, Wagner I, Miller K, et al. Reference miRNAs for miRNAome analysis of urothelial carcinomas. PLoS One. 2012;7(6):e39309.CrossRefPubMedPubMedCentral Ratert N, Meyer H-A, Jung M, Mollenkopf H-J, Wagner I, Miller K, et al. Reference miRNAs for miRNAome analysis of urothelial carcinomas. PLoS One. 2012;7(6):e39309.CrossRefPubMedPubMedCentral
29.
Zurück zum Zitat Li X, Zhang Y, Zhang H, Liu X, Gong T, Li M, et al. Mirna-223 promotes gastric cancer invasion and metastasis by targeting tumor suppressor epb41l3. Mol Cancer Res. 2011;9(7):824–33.CrossRefPubMed Li X, Zhang Y, Zhang H, Liu X, Gong T, Li M, et al. Mirna-223 promotes gastric cancer invasion and metastasis by targeting tumor suppressor epb41l3. Mol Cancer Res. 2011;9(7):824–33.CrossRefPubMed
30.
31.
Zurück zum Zitat Emmrich S, Henke K, Hegermann J, Ochs M, Reinhardt D, Klusmann J-H. MiRNAs can increase the efficiency of ex vivo platelet generation. Ann Hematol. 2012;91(11):1673–84.CrossRefPubMed Emmrich S, Henke K, Hegermann J, Ochs M, Reinhardt D, Klusmann J-H. MiRNAs can increase the efficiency of ex vivo platelet generation. Ann Hematol. 2012;91(11):1673–84.CrossRefPubMed
32.
Zurück zum Zitat Li X, Wang H-l, Peng X, Zhou H-l, Wang X. Mir-1297 mediates pten expression and contributes to cell progression in LSCC. Biochem Biophys Res Commun. 2012;427(9):254–60.CrossRefPubMed Li X, Wang H-l, Peng X, Zhou H-l, Wang X. Mir-1297 mediates pten expression and contributes to cell progression in LSCC. Biochem Biophys Res Commun. 2012;427(9):254–60.CrossRefPubMed
33.
Zurück zum Zitat Roy D, Dittmer DP. Phosphatase and tensin homolog on chromosome 10 is phosphorylated in primary effusion lymphoma and Kaposi’s sarcoma. Am J Pathol. 2011;179(4):2108–19.CrossRefPubMedPubMedCentral Roy D, Dittmer DP. Phosphatase and tensin homolog on chromosome 10 is phosphorylated in primary effusion lymphoma and Kaposi’s sarcoma. Am J Pathol. 2011;179(4):2108–19.CrossRefPubMedPubMedCentral
34.
Zurück zum Zitat Parker LH, Schmidt M, Jin S-W, Gray AM, Beis D, Pham T, et al. The endothelial-cell-derived secreted factor egfl7 regulates vascular tube formation. Nature. 2004;428(6984):754–8.CrossRefPubMed Parker LH, Schmidt M, Jin S-W, Gray AM, Beis D, Pham T, et al. The endothelial-cell-derived secreted factor egfl7 regulates vascular tube formation. Nature. 2004;428(6984):754–8.CrossRefPubMed
35.
Zurück zum Zitat Meister J, Schmidt MHH. Mir-126 and mir-126*: new players in cancer. Sci World J. 2010;10(9):2090–100.CrossRef Meister J, Schmidt MHH. Mir-126 and mir-126*: new players in cancer. Sci World J. 2010;10(9):2090–100.CrossRef
36.
Zurück zum Zitat Sodhi A, Montaner S, Patel V, Zohar M, Bais C, Mesri EA, et al. The Kaposi’s sarcoma-associated herpes virus g protein-coupled receptor up-regulates vascular endothelial growth factor expression and secretion through mitogen-activated protein kinase and p38 pathways acting on hypoxia-inducible factor 1 alpha. Cancer Res. 2000;60(17):4873–80.PubMed Sodhi A, Montaner S, Patel V, Zohar M, Bais C, Mesri EA, et al. The Kaposi’s sarcoma-associated herpes virus g protein-coupled receptor up-regulates vascular endothelial growth factor expression and secretion through mitogen-activated protein kinase and p38 pathways acting on hypoxia-inducible factor 1 alpha. Cancer Res. 2000;60(17):4873–80.PubMed
37.
Zurück zum Zitat Cai X, Lu S, Zhang Z, Gonzalez CM, Damania B, Cullen BR. Kaposi’s sarcoma-associated herpesvirus expresses an array of viral microRNAs in latently infected cells. Proc Natl Acad Sci U S A. 2005;102(15):5570–5.CrossRefPubMedPubMedCentral Cai X, Lu S, Zhang Z, Gonzalez CM, Damania B, Cullen BR. Kaposi’s sarcoma-associated herpesvirus expresses an array of viral microRNAs in latently infected cells. Proc Natl Acad Sci U S A. 2005;102(15):5570–5.CrossRefPubMedPubMedCentral
38.
Zurück zum Zitat Gottwein E, Mukherjee N, Sachse C, Frenzel C, Majoros WH, Chi JT, et al. A viral microRNA functions as an orthologue of cellular mir-155. Nature. 2007;450(7172):1096–9.CrossRefPubMedPubMedCentral Gottwein E, Mukherjee N, Sachse C, Frenzel C, Majoros WH, Chi JT, et al. A viral microRNA functions as an orthologue of cellular mir-155. Nature. 2007;450(7172):1096–9.CrossRefPubMedPubMedCentral
39.
Zurück zum Zitat Skalsky RL, Samols MA, Plaisance KB, Boss IW, Riva A, Lopez MC, et al. Kaposi’s sarcoma-associated herpesvirus encodes an ortholog of mir-155. J Virol. 2007;81(23):12836–45.CrossRefPubMedPubMedCentral Skalsky RL, Samols MA, Plaisance KB, Boss IW, Riva A, Lopez MC, et al. Kaposi’s sarcoma-associated herpesvirus encodes an ortholog of mir-155. J Virol. 2007;81(23):12836–45.CrossRefPubMedPubMedCentral
Metadaten
Titel
The expression profiles of microRNAs in Kaposi’s sarcoma
verfasst von
Xiu-Juan Wu
Xiong-Ming Pu
Zong-Feng Zhao
Ya-Nan Zhao
Xiao-Jing Kang
Wei-Dong Wu
Yun-Min Zou
Cao-Ying Wu
Yuan-Yuan Qu
De-Zhi Zhang
Yan-Yan Feng
Jian-Yong Liu
Publikationsdatum
01.01.2015
Verlag
Springer Netherlands
Erschienen in
Tumor Biology / Ausgabe 1/2015
Print ISSN: 1010-4283
Elektronische ISSN: 1423-0380
DOI
https://doi.org/10.1007/s13277-014-2626-1

Weitere Artikel der Ausgabe 1/2015

Tumor Biology 1/2015 Zur Ausgabe

Adjuvante Immuntherapie verlängert Leben bei RCC

25.04.2024 Nierenkarzinom Nachrichten

Nun gibt es auch Resultate zum Gesamtüberleben: Eine adjuvante Pembrolizumab-Therapie konnte in einer Phase-3-Studie das Leben von Menschen mit Nierenzellkarzinom deutlich verlängern. Die Sterberate war im Vergleich zu Placebo um 38% geringer.

Alectinib verbessert krankheitsfreies Überleben bei ALK-positivem NSCLC

25.04.2024 NSCLC Nachrichten

Das Risiko für Rezidiv oder Tod von Patienten und Patientinnen mit reseziertem ALK-positivem NSCLC ist unter einer adjuvanten Therapie mit dem Tyrosinkinase-Inhibitor Alectinib signifikant geringer als unter platinbasierter Chemotherapie.

Bei Senioren mit Prostatakarzinom auf Anämie achten!

24.04.2024 DGIM 2024 Nachrichten

Patienten, die zur Behandlung ihres Prostatakarzinoms eine Androgendeprivationstherapie erhalten, entwickeln nicht selten eine Anämie. Wer ältere Patienten internistisch mitbetreut, sollte auf diese Nebenwirkung achten.

ICI-Therapie in der Schwangerschaft wird gut toleriert

Müssen sich Schwangere einer Krebstherapie unterziehen, rufen Immuncheckpointinhibitoren offenbar nicht mehr unerwünschte Wirkungen hervor als andere Mittel gegen Krebs.

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.